Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas

Annals of Nuclear Medicine

Volumn 19, Issue 8, 2005, Pages 677-683

  Torii, Kenji ^a   Tsuyuguchi, Naohiro ^a   Kawabe, Joji ^a   Sunada, Ichiro ^a   Hara, Mitsuhiro ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11C methionine PET; Glioma; Ki 67LI

Indexed keywords

AMINO ACID; CARBON 11; KI 67 ANTIGEN; METHIONINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CHILD; CHOROID PLEXUS PAPILLOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; GLIOSIS; HUMAN; KAPLAN MEIER METHOD; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROEPITHELIOMA; OLIGODENDROGLIOMA; OPTIC NERVE GLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TERATOMA;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; METHIONINE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS; TISSUE DISTRIBUTION;

EID: 31744435047     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985116     Document Type: Article

References (24)

1. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 1986; 10: 611-617.
2. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001; 95: 746-750.
3. Dethy S, Goldman S, Blecic S, Luxen A, Levivier M, Hildebrand J. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma. J Nucl Med 1994; 35: 1162-1166.
4. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323-1329.
5. Ericson K, Blomqvist G, Bergstrom M, Eriksson L, Stone-Elander S. Application of a kinetic model on the methionine accumulation in intracranial tumours studied with positron emission tomography. Acta Radiol 1987; 28: 505-509.
6. 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 1985; 9: 683-689.
7. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710-1715.
8. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 1987; 74: 179-182.
9. 11C]methionine uptake in brain abscess: a PET study. J Comput Assist Tomogr 1993; 17: 660-661.
10. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 1994; 87: 47-54.
11. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-268.
12. 11C- methionine and positron emission tomography. AJNR Am J Neuroradiol 1985; 6: 505-514.
13. Ogawa T, Hatazawa J, Inugami A, Murakami M, Fujita H, Shimosegawa E, et al. Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. J Nucl Med 1995; 36: 2175-2179.
14. 11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 1991; 32: 197-202.
15. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816-822.
16. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res 1988; 8: 537-544.
17. Raghavan R, Steart PV, Weller RO. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study. Neuropathol Appl Neurobiol 1990; 16: 123-133.
18. Schroder R, Bien K, Kott R, Meyers I, Vossing R. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol (Berl) 1991; 82: 389-394.
19. 11C-methionine PET in choroid plexus papilloma-report of three cases. Radiat Med 2002; 20: 97-100.
20. 11C] methyl-L-methionine positron emission tomography of fibrous dysplasia-two case reports. Neurol Med Chir (Tokyo) 2002; 42: 341-345.
21. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 2003; 98: 1056-1064.
22. Tsuyuguchi N, Takami T, Sunada I, Iwai Y, Yamanaka K, Tanaka K, et al. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery-in malignant glioma. Ann Nucl Med 2004; 18: 291-296.
23. Tsuyuguchi N, Sunada I, Ohata K, Takami T, Nishio A, Hara M, et al. Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 2003; 17: 47-51.
24. Zuber P, Hamou MF, Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988; 22: 364-368.